Proficio Capital Partners LLC Buys New Holdings in Ingevity Co. (NYSE:NGVT)

Proficio Capital Partners LLC purchased a new position in shares of Ingevity Co. (NYSE:NGVT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 21,190 shares of the company's stock, valued at approximately $863,000. Proficio Capital Partners LLC owned 0.06% of Ingevity at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. Charles Schwab Investment Management Inc. raised its holdings in Ingevity by 6.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 646,267 shares of the company's stock worth $26,335,000 after buying an additional 38,639 shares during the period. Schechter Investment Advisors LLC increased its position in shares of Ingevity by 12.3% during the fourth quarter. Schechter Investment Advisors LLC now owns 29,876 shares of the company's stock worth $1,217,000 after acquiring an additional 3,271 shares in the last quarter. Oppenheimer Asset Management Inc. raised its holdings in shares of Ingevity by 7.9% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 27,770 shares of the company's stock worth $1,132,000 after acquiring an additional 2,031 shares during the period. Leeward Investments LLC MA lifted its position in Ingevity by 8.0% in the 4th quarter. Leeward Investments LLC MA now owns 189,347 shares of the company's stock valued at $7,716,000 after acquiring an additional 13,984 shares in the last quarter. Finally, Hudson Edge Investment Partners Inc. boosted its stake in Ingevity by 4.9% in the 4th quarter. Hudson Edge Investment Partners Inc. now owns 16,150 shares of the company's stock worth $658,000 after purchasing an additional 750 shares during the period. Institutional investors own 91.59% of the company's stock.

Remove Ads

Ingevity Stock Down 0.5 %

NYSE:NGVT traded down $0.21 on Tuesday, hitting $43.00. 136,838 shares of the company's stock were exchanged, compared to its average volume of 255,949. The company has a market cap of $1.56 billion, a P/E ratio of -3.63 and a beta of 1.53. The firm has a 50-day moving average price of $45.36 and a 200-day moving average price of $42.39. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. Ingevity Co. has a 52 week low of $30.90 and a 52 week high of $56.30.

Ingevity (NYSE:NGVT - Get Free Report) last released its earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.66. The business had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. As a group, analysts expect that Ingevity Co. will post 4.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on NGVT. BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. StockNews.com lowered Ingevity from a "buy" rating to a "hold" rating in a research report on Monday. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $55.17.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.